Delivery Order SPE2DR25D9314-SPE2DR26FKNM3
Award Date 2/17/26
Potential Completion Date 3/10/26
Potential Value $1.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 17, 2026, for YF-VAX 1 dose vials, with a ceiling value of $1,888.62. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations worldwide. DMS...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 13, 2026, for YF-VAX 1 dose vials with a ceiling value of $3,777.24. The order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a $499,999,999 ceiling through December 31, 2036. Place of...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 11, 2026, for YF-VAX 1 Dose Vials with a ceiling value of $1,888.62. The order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $499.999 billion program authorizing firm fixed-price delivery orders for pharmaceutical products and medical...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 5, 2026, with a ceiling value of $1,888.62 for YF-VAX 1 dose vials, with ultimate completion by February 27, 2026. DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler. The delivery order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a single-award indefinite delivery contract with a $499.999...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 17, 2026, for YF-VAX 1 dose vials with a ceiling value of $1,888.62. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. This delivery order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract that authorizes firm fixed-price delivery orders for pharmaceutical...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 9, 2026, for YF-VAX 1 dose vials with a ceiling value of $5,036.32. DMS Pharmaceutical Group is a woman-owned small business. The delivery order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract that authorizes firm fixed-price orders for pharmaceuticals and medical consumables to support Department of...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 10, 2026, for YF-VAX 1 dose vials with a ceiling value of $1,753.28. The order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. That IDC, awarded November 13, 2025, has a $499.999 billion ceiling and authorizes DLA to issue firm...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 17, 2026, for YF-VAX 1 dose vials with a ceiling value of $9,443.10. DMS Pharmaceutical Group Inc. is a woman-owned small business. This delivery order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract established to supply pharmaceutical products and medical consumables to Department of Defense...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 5, 2026, for YF-VAX 1 dose vials, with a ceiling value of $5,036.32. DMS Pharmaceutical Group is a woman-owned small business. The order is issued under the company's single-award Indefinite Delivery Contract with DLA under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a $499.999 billion ceiling and runs through December 31, 2036. Place of...
- The Defense Logistics Agency issued a $1,888.62 delivery order to DMS Pharmaceutical Group Inc. on February 3, 2026, for YF-VAX 1 dose vials, with an ultimate completion date of February 25, 2026. The order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.9 billion program supporting pharmaceutical supply to military...